|
1
|
Kotoulas CS, Foroulis CN, Kostikas K, et
al: Involvement of lymphatic metastatic spread in non-small cell
lung cancer accordingly to the primary cancer location. Lung
Cancer. 44:183–191. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stacker SA, Achen MG, Jussila L, Baldwin
ME and Alitalo K: Lymphangiogenesis and cancer metastasis. Nat Rev
Cancer. 2:573–583. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Franchi A, Gallo O, Massi D, Baroni G and
Santucci M: Tumor lymphangiogenesis in head and neck squamous cell
carcinoma: a morphometric study with clinical correlations. Cancer.
101:973–978. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dadras SS, Lange-Asschenfeldt B, Velasco
P, et al: Tumor lymphangiogenesis predicts melanoma metastasis to
sentinel lymph nodes. Mod Pathol. 18:1232–1242. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gombos Z, Xu X, Chu CS, Zhang PJ and Acs
G: Peritumoral lymphatic vessel density and vascular endothelial
growth factor C expression in early-stage squamous cell carcinoma
of the uterine cervix. Clin Cancer Res. 11:8364–8371. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen SX, Li XY, Kong XL and Feng Y: The
expression of vascular endothelial growth factor-C in oral squamous
cell carcinoma and its association with angiogenesis,
lymphangiogenesis and lymph node metastasis. West China Journal of
Stomatology. 28:319–323. 2010.(In Chinese).
|
|
7
|
Kubo H, Cao R, Brakenhielm E, et al:
Blockade of vascular endothelial growth factor receptor-3 signaling
inhibits fibroblast growth factor-2-induced lymphangiogenesis in
mouse cornea. Proc Natl Acad Sci USA. 99:8868–8873. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vincent L and Rafii S: Vascular frontiers
without borders: multifaceted roles of platelet-derived growth
factor (PDGF) in supporting postnatal angiogenesis and
lymphangiogenesis. Cancer Cell. 6:307–309. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kajiya K, Hirakawa S, Ma B, Drinnenberg I
and Detmar M: Hepatocyte growth factor promotes lymphatic vessel
formation and function. EMBO J. 24:2885–2895. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Björndahl M, Cao R, Nissen LJ, et al:
Insulin-like growth factors 1 and 2 induce lymphangiogenesis in
vivo. Proc Natl Acad Sci USA. 102:15593–15598. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sedivy R, Beck-Mannagetta J, Haverkampf C,
Battistutti W and Hönigschnabl S: Expression of vascular
endothelial growth factor-C correlates with the lymphatic
microvessel density and the nodal status in oral squamous cell
cancer. J Oral Pathol Med. 32:455–460. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Swoboda A, Schanab O, Tauber S, et al: MET
expression in melanoma correlates with a lymphangiogenic phenotype.
Hum Mol Genet. 21:3387–3396. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim CH, Moon SK, Bae JH, et al: Expression
of hepatocyte growth factor and c-Met in hypopharyngeal squamous
cell carcinoma. Acta Otolaryngol. 126:88–94. 2006. View Article : Google Scholar
|
|
14
|
Amemiya H, Kono K, Itakura J, et al: c-Met
expression in gastric cancer with liver metastasis. Oncology.
63:286–296. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jedeszko C, Victor BC, Podgorski I and
Sloane BF: Fibroblast hepatocyte growth factor promotes invasion of
human mammary ductal carcinoma in situ. Cancer Res. 69:9148–9155.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Knudsen BS, Gmyrek GA, Inra J, et al: High
expression of the Met receptor in prostate cancer metastasis to
bone. Urology. 60:1113–1117. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Takeuchi H, Bilchik A, Saha S, et al:
c-MET expression level in primary colon cancer: a predictor of
tumor invasion and lymph node metastases. Clin Cancer Res.
9:1480–1488. 2003.PubMed/NCBI
|
|
18
|
Jiang W, Hiscox S, Matsumoto K and
Nakamura T: Hepatocyte growth factor/scatter factor, its molecular,
cellular and clinical implications in cancer. Crit Rev Oncol
Hematol. 29:209–248. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gentile A and Comoglio PM: Invasive
growth: a genetic program. Int J Dev Biol. 48:451–456. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Trusolino L and Comoglio PM:
Scatter-factor and semaphorin receptors: cell signalling for
invasive growth. Nat Rev Cancer. 2:289–300. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Salgia R: Role of c-Met in cancer:
emphasis on lung cancer. Semin Oncol. 36(Suppl 1): S52–S58. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Davies G, Mason MD, Martin TA, et al: The
HGF/SF antagonist NK4 reverses fibroblast- and HGF-induced prostate
tumor growth and angiogenesis in vivo. Int J Cancer. 106:348–354.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
You WK and McDonald DM: The hepatocyte
growth factor/c-Met signaling pathway as a therapeutic target to
inhibit angiogenesis. BMB Rep. 41:833–839. 2008. View Article : Google Scholar
|
|
24
|
Fleming ID, Phillips JL, Menck HR, Murphy
GP and Winchester DP: The National Cancer Data Base report on
recent hospital cancer program progress toward complete American
Joint Committee on Cancer/TNM staging. Cancer. 80:2305–2310. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hensing TA: Clinical evaluation and
staging of patients who have lung cancer. Hematol Oncol Clin North
Am. 19:219–235. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hasina R, Whipple ME, Martin LE, et al:
Angiogenic heterogeneity in head and neck squamous cell carcinoma:
biological and therapeutic implications. Lab Invest. 88:342–353.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Weidner N: Current pathologic methods for
measuring intratumoral microvessel density within breast carcinoma
and other solid tumors. Breast Cancer Res Treat. 36:169–180. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Adachi Y, Nakamura H, Kitamura Y, et al:
Lymphatic vessel density in pulmonary adenocarcinoma
immunohistochemically evaluated with anti-podoplanin or anti-D2–40
antibody is correlated with lymphatic invasion or lymph node
metastases. Pathol Int. 57:171–177. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Olivero M, Rizzo M, Madeddu R, et al:
Overexpression and activation of hepatocyte growth factor/scatter
factor in human non-small-cell lung carcinomas. Br J Cancer.
74:1862–1868. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Edakuni G, Sasatomi E, Satoh T, Tokunaga O
and Miyazaki K: Expression of the hepatocyte growth factor/c-Met
pathway is increased at the cancer front in breast carcinoma.
Pathol Int. 51:172–178. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ichimura E, Maeshima A, Nakajima T and
Nakamura T: Expression of c-met/HGF receptor in human non-small
cell lung carcinomas in vitro and in vivo and its prognostic
significance. Jpn J Cancer Res. 87:1063–1069. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Takanami I, Tanana F, Hashizume T, et al:
Hepatocyte growth factor and c-Met/hepatocyte growth factor
receptor in pulmonary adenocarcinomas: an evaluation of their
expression as prognostic markers. Oncology. 53:392–397. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Siegfried JM, Weissfeld LA, Singh-Kaw P,
et al: Association of immunoreactive hepatocyte growth factor with
poor survival in resectable non-small cell lung cancer. Cancer Res.
57:433–439. 1997.PubMed/NCBI
|
|
34
|
Toschi L and Cappuzzo F: Clinical
implications of MET gene copy number in lung cancer. Future Oncol.
6:239–247. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cao R, Björndahl MA, Gallego MI, et al:
Hepatocyte growth factor is a lymphangiogenic factor with an
indirect mechanism of action. Blood. 107:3531–3536. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kahn HJ, Bailey D and Marks A: Monoclonal
antibody D2–40, a new marker of lymphatic endothelium, reacts with
Kaposi’s sarcoma and a subset of angiosarcomas. Mod Pathol.
15:434–440. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Faoro L, Hutto JY, Salgia R, et al:
Lymphatic vessel density is not associated with lymph node
metastasis in non-small cell lung carcinoma. Arch Pathol Lab Med.
132:1882–1888. 2008.PubMed/NCBI
|
|
38
|
Padera TP, Kadambi A, di Tomaso E, et al:
Lymphatic metastasis in the absence of functional intratumor
lymphatics. Science. 296:1883–1886. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cao Y and Zhong W: Tumor-derived
lymphangiogenic factors and lymphatic metastasis. Biomed
Pharmacother. 61:534–539. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Saito Y, Nakagami H, Morishita R, et al:
Transfection of human hepatocyte growth factor gene ameliorates
secondary lymphedema via promotion of lymphangiogenesis.
Circulation. 114:1177–1184. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Cao R, Ji H, Feng N, et al: Collaborative
interplay between FGF-2 and VEGF-C promotes lymphangiogenesis and
metastasis. Proc Natl Acad Sci USA. 109:15894–15899. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Cimpean AM, Seclaman E, Ceauşu R, et al:
VEGF-A/HGF induce Prox-1 expression in the chick embryo
chorioallantoic membrane lymphatic vasculature. Clin Exp Med.
10:169–172. 2010. View Article : Google Scholar
|
